Deficiencies in current evaluations of the cost-effectiveness of biologic agents for RA.
van den Hout
Wilbert B
WB
Department of Medical Decision Making, Leiden University Medical Centre, Leiden, The Netherlands. w.b.van_den_hout@lumc.nl
D018501:Antirheumatic Agents / Q000191:economics* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000191:economics* / Q000503:physiopathology; D003362:Cost-Benefit Analysis; D006801:Humans; D007155:Immunologic Factors / Q000191:economics* / Q000627:therapeutic use; D019057:Quality-Adjusted Life Years
D018501:Antirheumatic Agents; D007155:Immunologic Factors